Table 2.

Table 2 Psychopathology measures at pre-treatment, post-treatment and follow-up (mean±SD)

Measure	CBT	Treatment as usual	F (df = 25)	p	ή	Between condition
	(n= 16)	(n= 12)				effect size
Pre-treatment
PSS	26.8±10.0	22.7±12.4	0.93	0.34	0.03	-0.36 (95% CI: -0.40-1.11)
BDI-II	22.3±13.4	17.8±14.7	0.71	0.41	0.03	-0.31 (95% CI: -0.44-1.06)
ICG	24.3±10.2	24.2±10.1	1.32	0.26	0.05	0.01 (95% CI: -0.74-0.76)
Post-treatment
PSS	4.1±8.0	12.3±8.4	13.49	0.001	0.35	0.96 (95% CI: 0.17-1.75)
BDI-II	3.2±87	11.3±11.3	10.12	0.004	0.29	0.81 (95% CI: 0.03-1.58)
ICG	10.7±5.8	15.2±9.3	14.52	0.001	0.37	0.58 (95% CI: -0.18-1.35)
Follow-up
PSS	7.5±11.1	15.2±13.1	8.63	0.007	0.26	0.62 (95% CI: -0.14-1.39)
BDI-II	6.4±12.2	11.0±11.6	11.15	0.003	0.31	0.37 (95% CI: -0.38-1.13)
ICG	11.5±7.2	14.8±9.4	10.94	0.003	0.30	0.38 (95% CI: -0.37-1.38)
CBT – cognitive behavior therapy; PSS – PTSD Symptom Scale; BDI-II – Beck Depression Inventory, 2nd ed.; ICG – Inventory for Complicated Grief